1-4 of 4
Dina Lev
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors

Markus P. Ghadimi, Gonzalo Lopez, Keila E. Torres, Roman Belousov, Eric D. Young, Jeffery Liu, Kari J. Brewer, Aviad Hoffman, Kristelle Lusby, Alexander J. Lazar, Raphael E. Pollock, Dina Lev
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (8): 1758–1769.
https://doi.org/10.1158/1535-7163.MCT-12-0015
Published: 08 August 2012
View article titled, Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors
Open the PDF for Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors in another window
Includes: Supplementary data
Journal Articles

Doxorubicin Resistance in a Novel In vitro Model of Human Pleomorphic Liposarcoma Associated with Alternative Lengthening of Telomeres

Marcy A. Mitchell, Jay E. Johnson, Kara Pascarelli, Neil Beeharry, Maria Chiourea, Sarantis Gagos, Dina Lev, Margaret von Mehren, David Kipling, Dominique Broccoli
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (3): 682–692.
https://doi.org/10.1158/1535-7163.MCT-09-0705
Published: 09 March 2010
View article titled, Doxorubicin Resistance in a Novel <em>In vitro</em> Model of Human Pleomorphic Liposarcoma Associated with Alternative Lengthening of Telomeres
Open the PDF for Doxorubicin Resistance in a Novel <em>In vitro</em> Model of Human Pleomorphic Liposarcoma Associated with Alternative Lengthening of Telomeres in another window
Includes: Supplementary data
Journal Articles

Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor

Changye Y. Zou, Kerrington D. Smith, Quan-Sheng Zhu, Jun Liu, Ian E. McCutcheon, John M. Slopis, Funda Meric-Bernstam, Zhenghong Peng, William G. Bornmann, Gordon B. Mills, Alexander J. Lazar, Raphael E. Pollock, Dina Lev
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (5): 1157–1168.
https://doi.org/10.1158/1535-7163.MCT-08-1008
Published: 13 May 2009
View article titled, Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor
Open the PDF for Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor in another window
Journal Articles

Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation

Jonathan A.F. Hannay, Juehui Liu, Quan-Sheng Zhu, Svetlana V. Bolshakov, Lan Li, Peter W.T. Pisters, Alexander J.F. Lazar, Dihua Yu, Raphael E. Pollock, Dina Lev
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (5): 1650–1660.
https://doi.org/10.1158/1535-7163.MCT-06-0636
Published: 18 May 2007
View article titled, Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation
Open the PDF for Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation in another window